CompletedNCT04046926
Relapse in Eating disorders. A Cohort Study
This summary needs review. Please check the official study record and contact the research team for details.
In GardaEating disordersOtherFrom 13 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
TerminatedISRCTN20556456
Relapse prevention among schizophrenia: A multi stage controlled group study.
This study was terminated in the United Kingdom. It focuses on schizophrenia.
In United KingdomSchizophreniaOther
CompletedNCT00044616
Relapse Prevention for Bipolar Type-II Disorder
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
In PhiladelphiaBipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 100 Years
CompletedNCT00589641
Relapse Prevention for Suicidal Dually Diagnosed Youths
This summary needs review. Please check the official study record and contact the research team for details.
In DurhamDepressionBehavioralFrom 13 Years to 19 Years
WithdrawnNCT04553263
Relapse Prevention in Addiction
This study exists to see whether smoking support or smoking-related treatment can make care clearer and more responsive. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.
In Los AngelesAddiction, ADHDDrugFrom 18 Years to 65 Years
CompletedEUCTR 2008-003877-42
Relapse prevention in people with major depression treated with electroconvulsive therapy using a fixed dose range of escitalopram compared to a fixed dose of nortriptyline (DUAG-7) A ...
This study is completed in Denmark. It focuses on depression.
In DenmarkDepressionOther
WithdrawnNCT00793468
Relapse Prevention Study in Newly Abstinent Smokers
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including DeLandAddictionDrugFrom 18 Years to 65 Years
CompletedNCT01291511
Relapse Prevention Study in people with Schizophrenia
This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
Multiple locations, including AnaheimSchizophreniaDrugFrom 18 Years to 65 Years
CompletedNCT03325556
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Costa MesaSchizophreniaDrugFrom 50 Years to 90 Years
CompletedNCT00228462
Prevention of Relapse for schizophrenia
This study is completed in Bulgaria and in Poland. It is testing prevention of Relapse for schizophrenia.
Multiple locations, including BurgasSchizophreniaDrugFrom 18 Years to 65 Years
CompletedNCT04578314
RELATE - Efficacy and Feasibility of a Cognitive Behavioural Module for Distressing Auditory Verbal Hallucinations
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.
Multiple locations, including LeipzigSchizophreniaBehavioralOver 16 Years
OngoingEUCTR 2013-001818-14
RELATE and PREDICT TRD A pharmacological and neuroimaging study investigating neurobiological effects of Selective Serotonin Reuptake Inhibitors and Norepinephrine Reuptake inhibitors on dopaminer...
This study is ongoing in the Netherlands. It focuses on Depression.
In NetherlandsDepressionOther
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.